Literature DB >> 19379880

Reoperative mitral valve surgery by the port access minithoracotomy approach is safe and effective.

Steven R Meyer1, Wilson Y Szeto, John G T Augoustides, Rohinton J Morris, William J Vernick, Deborah Paschal, Jeanne Fox, W Clark Hargrove.   

Abstract

BACKGROUND: Reoperative mitral valve (MV) surgery through sternotomy can be technically challenging. Limited exposure and injury to the right ventricle or patent grafts (previous coronary artery bypass graft surgery [CABG]) are potential complications upon sternal reentry. The purpose of this study was to examine the results of port access MV surgery through right minithoracotomy in patients with previous cardiac surgery performed through median sternotomy.
METHODS: From 1998 through July 2007, 651 port access MV procedures were performed. In 107 patients (16.4%), previous cardiac surgery had been performed through midline sternotomy. Mean age was 67.5 +/- 11.2 years, and 60.7% (n = 65) were male. Previous surgery included CABG (n = 45, 42.1%), aortic valve replacement (n = 9, 8.4%), aortic valve replacement/MV repair (n = 2, 1.9%), MV repair (n = 21, 19.6%), MV replacement (n = 5, 4.7%), CABG/MV replacement (n = 1, 0.9%), CABG/MV repair (n = 8, 7.5%), CABG/aortic valve replacement (n = 2, 1.9%), and others (n = 14, 13.1%). New York Heart Association functional classes were I (n = 2, 1.9%), II (n = 28, 26.2%), III (n = 50, 46.7%), and IV (n = 27, 25.2%). The endoaortic balloon was used in 75 patients (70.1%) and the Chitwood clamp in 11 patients (10.2%). In the remaining patients (n = 21, 19.6%), fibrillatory arrest was employed.
RESULTS: Mitral valve repair and MV replacement were performed in 60 patients (56.1%) and 47 patients (43.9%), respectively. The 30-day mortality was 4.7% (n = 5). The mean cardiopulmonary bypass and aortic cross-clamp times were 140.8 +/- 43.7 minutes and 77.0 +/- 49.7 minutes, respectively. Complications included 6 reoperations for bleeding (5.6%), 1 stroke (0.9%), and 2 wound infections (1.9%). Conversion to sternotomy was required in 1 patient (0.9%) because of an acute type A dissection secondary to aortic occlusion with Chitwood clamp. The mean hospital stay was 9.6 days. During follow-up, reoperation for failure of MV repair was performed in 4 patients (3.7%).
CONCLUSIONS: Reoperative port access MV surgery can be performed with minimal morbidity and mortality. This approach may be the preferred technique for patients who require MV procedures after previous cardiac surgery performed through median sternotomy.

Entities:  

Mesh:

Year:  2009        PMID: 19379880     DOI: 10.1016/j.athoracsur.2009.02.060

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

Review 1.  Repeated valve replacement surgery: technical tips and pitfalls.

Authors:  Kazuo Tanemoto; Hiroshi Furukawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-09-19

Review 2.  Percutaneous and surgical treatment of mitral valve regurgitation.

Authors:  Joerg Seeburger; Hugo A Katus; Sven T Pleger; Ulrike Krumsdorf; Friedrich-Wilhelm Mohr; Raffi Bekeredjian
Journal:  Dtsch Arztebl Int       Date:  2011-12-02       Impact factor: 5.594

3.  Port-access mitral valve replacement after surgical correction for Bland-White-Garland syndrome.

Authors:  Kosaku Nishigawa; Masahiko Kuinose; Yoshimasa Tsushima; Toshinori Totsugawa; Hidenori Yoshitaka; Genta Chikazawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-03-30

4.  Robotic mitral valve surgery after prior sternotomy.

Authors:  Talia G Meidan; Allison T Lanfear; John J Squiers; Mohanad Hamandi; Bruce W Lytle; J Michael DiMaio; Robert L Smith
Journal:  JTCVS Tech       Date:  2022-02-24

5.  Comparative analysis of thoracotomy and sternotomy approaches in cardiac reoperation.

Authors:  Dong Chan Kim; Hyun Keun Chee; Meong Gun Song; Je Kyoun Shin; Jun Seok Kim; Song Am Lee; Jae Bum Park
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-08-03

6.  Higher-risk mitral valve operations after previous sternotomy: endoscopic, minimally invasive approach improves patient outcomes.

Authors:  Katie L Losenno; Philip M Jones; Matthew Valdis; Stephanie A Fox; Bob Kiaii; Michael W A Chu
Journal:  Can J Surg       Date:  2016-12       Impact factor: 2.089

7.  Mitral valve reoperation under ventricular fibrillation through right mini-thoracotomy using three-dimensional videoscope.

Authors:  Arudo Hiraoka; Masahiko Kuinose; Toshinori Totsugawa; Genta Chikazawa; Hidenori Yoshitaka
Journal:  J Cardiothorac Surg       Date:  2013-04-12       Impact factor: 1.637

8.  Robotic mitral valve replacements with bioprosthetic valves in 52 patients: experience from a tertiary referral hospital.

Authors:  Chia-Cheng Kuo; Hsiao-Huang Chang; Chung-Hsi Hsing; Hiong-Ping Hii; Nan-Chun Wu; Chin-Ming Hsu; Chun-I Chen; Bor-Chih Cheng
Journal:  Eur J Cardiothorac Surg       Date:  2018-11-01       Impact factor: 4.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.